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Abstract: We followed 858 children from birth to one year of
age to determine whether the presence of polychlorinated biphenyls
(PCBs) and dichlorodiphenyl dichloroethene (DDE) in breast milk
affected their growth or health. Neither chemical showed an adverse
effect on weight or frequency of physician visits for various illnesses,
although differences were seen between breast-fed and bottle-fed
children, with bottle-fed children being heavier and having more
frequent gastroenteritis and otitis media. Children of mothers with
higher levels ofDDE were breast-fed for markedly shorter times, but
adjustments for possible confounders and biases did not change the
findings. In absence of any apparent effect on the health of the
children, we speculate that DDE may be interfering with the
mother's ability to lactate, possibly because of its estrogenic prop-
erties. (Am J Public Health 1987; 77:1294-1297.)
Introduction
Laug, et al, reported the presence of the pesticide
dichlorodiphenyl trichloroethane (DDT) in human milk in
1951.1 Surveys over three decades in many parts of the world
have shown that DDT or the stable metabolite dichlorodi-
phenyl dichloroethene (DDE) is detectable in almost all
samples of human adipose tissue or the fat of human breast
milk.2 Polychlorinated biphenyls (PCBs), which are electrical
insulating compounds, have been reported as contaminants
of human milk since 1966.3 Surveys of breast milk show
widespread prevalence of PCB contamination in industrial-
ized countries.2'4'5 Quantitatively, PCBs and DDT/DDE are
the most important of the several organochlorine compounds
that have been detected in human milk. Infant formula and
commercial milk (in the United States) are essentially free of
PCBs and DDT/DDE.
We began a project in 1978 in which we measured PCBs
and DDE in breast milk and followed children to determine
any effects on their health, growth, and development, includ-
ing duration of lactation. We report here findings for the first
year of life.
Methods
The North Carolina Breast Milk and Formula Project is a
prospective birth cohort study that enrolled about 900 families
between 1978 and 1982. Study design, chemical analysis meth-
ods, characteristics of the cohort, and findings on neonatal
examination are given elsewhere.`7 Briefly, any mother who
planned to deliver at one of three cooperating institutions and
who would be available for at least six months offollow-up was
allowed to enroll. The women who volunteered were predom-
inantly White (92 per cent) and well educated. The children
were seen at birth, six weeks, 3, 6, 12, and 18 months, and then
yearly until age five. Breast milk, formula, or whatever the child
was fed was collected at each visit until six months; after that,
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only breast milk was collected until the mother ceased lactation.
Maternal serum, cord blood, and placenta were also collected.
The children were examined and a medical history was taken at
each visit; the mother was also asked about weaning. Medical
records were abstracted. Of the 930 children whose mothers
volunteered for the study, 858 participated beyond birth. Of the
858, 802 (93 per cent) were still participating at one year of age.
All biological samples and a 10 per cent sample of
formula specimens were analyzed for PCBs and p,p'-DDE
(all formula samples were essentially negative). PCB/DDE
concentrations in milk at birth were estimated by combining
all samples as described elsewhere.5 Concentrations decline
over the course of lactation; for example, concentrations of
PCBs at six weeks averaged 93 per cent of concentrations at
birth. To estimate a woman's concentration at any specific
time point, the average decline was applied; values between
visits were obtained by linear interpolation.
Duration of breast-feeding was reported as both the time
during which the mother reported that the child was "most-
ly" breast-fed and the time until total cessation of breast-
feeding. Reasons for weaning came from the answer chosen
to a question that gave the mother several options (for
example, "thought it was the usual time," "doctor advised
it") or allowed her to provide her own answer if none (of the
multiple choice responses) were suitable.
To examine the relation between PCBs and DDE and
morbidity, we needed to assign a dose to each child. Dose is
determined by three conditions: the concentrations of
PCB/DDE in the fat of breast milk, the amount of fat in the
milk, and the amount of milk consumed by the infant. We do
not have enough data to deal with sustained differences in
amount of milk fat among mothers, and thus use an average.
PCB/DDE concentration and duration information were
combined to provide estimated amounts of PCBs and DDE
consumed. Milk was assumed to average 2.5 per cent fat over
the entire lactation. We assumed that children consumed 700
g ofmilk daily as long as they were mostly breast-fed, and half
that amount afterward until breast-feeding stopped. For this
calculation, the time mostly breast-fed was taken to be at
most nine months. This calculation is similar to that of
Wickizer and Brilliant.8 Note that although we have attempt-
ed to estimate absolute dose, only the relative dose is
important for determining the trend with increasing dose.
Illnesses were counted as recorded in the child's medical
records, and represent data from visits to a physician or other
health care provider. No attempt was made to verify diagnoses.
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TABLE 1-Duration of Lactation and Percentage of Women with Lactation
Failure by Chemical Levels*
Chemical No. of Median % with
Levels Women Weeks Lactation Failure
DDE
0.31- 0.99 54 26 5
1.00- 1.99 205 26 6
2.00- 2.99 217 23 6
3.00- 3.99 135 24 8
4.00- 4.99 48 18 15
5.00- 5.99 27 9 24
6.00-23.80 48 10 10
PCBs
0.49- 0.99 43 26 5
1.00- 1.49 192 25 8
1.50- 1.99 232 24 9
2.00- 2.49 134 23 7
.2.50- 2.99 60 18 10
3.00- 3.49 31 26 10
3.50- 3.99 18 26 0
4.00-15.80 24 13 13
*Amounts of DDE and PCBs are estimated concentrations in mother's milk fat at birth
in parts per million. Weeks represent number of weeks child was mostly breast-fed. See text
for definition of lactation failure used here.
Study personnel usually did not provide care. Illness reports
were reviewed centrally, any necessary clarification was sought
from field personnel, and the individual illnesses were grouped
into similar categories. Weights were obtained from the physical
examination at each study visit; when a visit was missed,
weights were taken from medical records if possible.
In general, neither mothers nor study personnel were
aware of the results of the chemical analyses until the child
was at least two years old. Observations concerning chemical
exposures are therefore double blind. Women who had two
children in the study knew the results from their first set of
analyses during their second lactation.
Results
About 88 per cent of the children in the study were
breast-fed. This figure does not apply to all women who gave
birth at these institutions, and probably reflects the height-
ened interest participating families had in infant nutrition.
Women with higher levels of DDE and perhaps PCBs had
shorter lactations (Table 1). We did a multiple linear regres-
sion analysis in which duration of breast-feeding (i.e., weeks
mostly on the breast) was the dependent variable, and
mother's age, race, education, occupation, smoking, drink-
ing, and estimated PCB and DDE concentrations in milk at
birth were the independent variables (there was also a marker
term for the three data collection sites). Table 2 shows the
regression coefficients. In this model, the coefficients for
DDE and for PCBs are negative, i.e., higher levels are
associated with shorter lactation. There is a decline in
duration of lactation of about one week for each additional
ppm of chemical. There are also differences by occupation,
with women who identify themselves as students or house-
wives breast-feeding longer. Better educated and older moth-
ers breast-feed longer than younger ones, and non-smokers
longer than smokers." I The correlation between PCBs and
DDE is only .23, so the effects of the chemicals are not
confounded.
We have shown elsewhere that levels ofPCBs and DDE
decline over the course of lactation, and that levels seen in a
first lactation are higher than those seen in subsequent ones.5
That finding produces a problem in this analysis if one posits
the existence of a group of women who have breast-fed a
TABLE 2-Results of Regression of Duration of Lactation on Chemical Levels and Other Factors in All
Lactations and First Lactations
All Lactations First Lactations Only
95% Confidence 95% Confidence
Coefficient Interval Coefficient Interval
Matemal age (years) 0.9 (0.5, 1.2) 0.8 (0.3, 1.3)
Maternal race
White 0 - 0
Black -2.3 (-9.3, 4.8) -5.6 (-14.4, 3.1)
Other 3.1 (-20.5, 26.7) 1.7 (-21.8, 25.2)
Maternal education (years) 1.1 (0.3, 1.9) 1.0 (0.1, 2.0)
Maternal occupation
White collar -12.2 (-19.5, -5-0) -15.3 (-23.4, -7.2)
Professional -10.0 (-17.0, -3.1) -10.7 (-18.4, -3.1)
Laborer/farmer -9.6 (-19.3, 0.1) -8.9 (-19.6, 1.8)
Paraprofessional -5.3 (-13.3, 2.7) -9.8 (-18.7, -0.9)
Housewife -1.6 (-9.0, 5.9) -5.2 (-14.1, 3.7)
Student 0 - 0
Maternal smoking
No 4.8 (1.4, 8.3) 3.9 (-0.3, 7.9)
Yes 0 - 0
Maternal alcohol
< one drink per week 0.9 (-1.7, 3.5) 1.2 (-2.0, 4.4)
> = one drink per week 0 - 0
Study area
Pitt -3.5 (-6.6, -0.5) -2.4 (-6.0, 1.3)
Durham -2.3 (-5.2, 0.6) -1.3 (-4.9, 2.3)
Wake 0 - 0
PCBs (ppm in milk fat) -1.1 (-2.2, 0.1) -0.7 (-1.9, 0.6)
DDE (ppm in milk fat) -1.1 (-1.7, -0.5) -0.9 (-1.7, -0.1)
Dependent variable in regression is number of weeks mostly breast-fed. Independent variables are the factors listed. For categorical
factors, the reference category is shown with a coefficient of zero and no confidence interval.
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TABLE 3-Per Cent of Children Ever Having Upper Respiratory Infection (URI), Otits Media (Ear), or Gastroeteritis (GI) in Various Age Intervals by Feeding
Method and Contaminant Amounts
0-3 Months 3-6 Months 6-12 Months
% Ever Having % Ever Having % Ever Having
No. of No. of No. of
mg Children URI Ear GI mg Children URI Ear GI mg Children URI Ear GI
Bottle-feoders 80 16 18 24 80 28 33 13 80 48 58 25
Ex-breast-feeders - - - - 172 35 39 14 321 54 63 29
Breast-feeders 689 21 11 11 503 24 22 6 353 49 52 17
PCBs
0-1 74 36 22 27 0-1 71 37 25 10 0-1 54 33 50 17
1-2 194 20 14 11 1-2 180 24 29 5 1-2 84 62 65 21
2-3 238 22 9 8 2-3 164 23 14 6 2-3 95 48 48 15
3-5 145 13 8 6 3-4 51 12 14 4 3-4 69 54 47 16
5+ 38 11 5 16 4+ 37 16 22 3 4+ 51 41 47 18
DDE
0-2 201 25 18 15 0-1 72 33 25 7 0-1 54 35 50 13
2-3 153 25 12 9 1-2 113 23 23 4 1-2 64 55 55 9
3-5 214 14 7 7 2-3 119 25 29 6 2-3 67 54 54 18
5-8 89 18 6 11 3-5 143 21 15 7 3-5 96 51 52 20
8+ 32 19 6 17 5+ 56 16 16 4 5+ 72 49 51 24
For each time period, children are divided into bottle-feeders, ex-breast-feeders, and current breast-feeders. Current breast-feeders are further divided by the estimated amount (mg) of
PCBs and DDE consumed during the time period. Entries are the per cent of children ever having the disease during the time period. Diseases are upper respiratory infections (URI), otitis media
(ear), and gastroenteritis (GI).
previous child and who breast-feed a long time for reasons
that we did not measure and thus cannot adjust for. Such
women will have reduced their body burden by their longer
lactations, and thus will start out their study lactation at a
lower level. They will then proceed to breast-feed for a long
time, thus producing an artifactual relationship between
lower levels and duration. The simplest way to address this
problem is to confine the analysis to women who have not
previously breast-fed. This restriction reduces the number
available for the analysis by 36 per cent (Table 2). The effects
ofDDE, education, occupation, smoking, and age are similar
to those estimated in the previous analysis; the wider inter-
vals are due to the smaller sample size. Some of the PCB
effect appears artifactual since its estimate nearly is halved.
The association between DDE and duration of lactation
could have occurred because employed women had to go
back to work earlier and also had higher levels. We thus
separated the reasons given for weaning into those relating to
the child's progress (insufficient milk, poor weight gain, baby
allergic to milk, baby had difficulty breast-feeding, baby
became ill) and social, occupational or other reasons (incon-
venient, back to work, breast infection, mother became ill).
We defined lactational failure operationally as short duration
of lactation (at most one month mostly breast-fed and two
months until final weaning) caused by a reason from the
former group. Table 1 shows that higher levels of DDE (but
not PCBs) are associated with higher rates of lactational
failure. If we restrict to women who have not previously
breast-fed, the patterns are unchanged.
The three most common reasons for doctor visits were
upper respiratory illness (including cold, flu, sore throat, and
similar symptoms), otitis media, and gastroenteritis (includ-
ing diarrhea, vomiting, etc.). Table 3 shows the per cent of
children with these illnesses during three time periods: 0-3
months, 3-6 months, and 6-12 months. By looking within
relatively short intervals, we hoped to alleviate some of the
potential confounding arising since illness can terminate
breast-feeding. 12 Within the intervals, the children are divid-
ed into those who never breast-fed, those who previously
breast-fed but are now weaned, and those who breast-fed at
some time during the period. Those who breast-fed during the
period are further subdivided into groups by estimated
amount of PCBs and DDE consumed during the period.
None of these diseases showed any evidence of harmful
effects ofPCBs orDDE; in fact, the trends usually were in the
other direction. The only strong upward trend with dose was
for gastroenteritis and DDE in the 6-12 month period; as
there is no discernible trend in the other time periods, this
may be a chance finding. Note also that the gastroenteritis
rate seen at the highest DDE levels is comparable to that seen
among bottle-feeders. The apparent beneficial effects ofthese
chemicals are presumably artifactual, and arise because
lower cumulative doses are partially produced by weaning
early in the time period, sometimes because the child is ill.
We also did analyses (data not shown) confined to children
who continued to breast-feed, thus eliminating the weaning
problem. The results are essentially similar.
We examined eczemna, asthma, other allergy, and lower
respiratory infections. These are all relatively rare at this age.
There are no differences between breast-fed and bottle-fed
children. There is a negative association between PCBs and
lower respiratory illness and between DDE levels and aller-
gy. Analysis ofweight gain showed the familiar lighter weight
among breast-fed children, but no effect of PCBs or DDE.
Tabular data for all these analyses are available from the
authors.
Discussion
The levels of PCBs and DDE seen in this study are as
high as have been observed in the US outside of specific
high-exposure situations.5 Close comparisons among studies
are notjustified, since analytic methods differ, but PCB levels
in these data are as high or higher than those seen in Michigan
among women who regularly ate contaminated Lake Mich-
igan fish. Thus the lack of morbidity seen here is reassuring.
More rapid weight gain is known to occur among
bottle-fed children,'3 and its interpretation is not clear. For
our purposes, the issue of which weight is optimal is sec-
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ondary to the point that the weights do not vary by chemical
level.
We see little evidence for an effect of chemical levels on
morbidity. The only trends seen are a decrease in upper
respiratory infections with PCBs early in lactation and an
increase in gastroenteritis with DDE late in lactation. A small
increase in specific illnesses cannot be ruled out, of course.
We hypothesize that the shorter duration of breast-feed-
ing we see is more likely due to an inhibitory effect on
lactation by the chemicals than to production of illness in the
child and subsequent weaning. This hypothesis is consistent
with the lack of association between DDE or PCB levels and
increased rates of illness. DDE is a reasonable candidate to
produce such toxicity. The o,p' form of DDE (and DDT) is
a weak estrogen in various animal test systems'4; although we
measured p,p'-DDE, o,p'-DDE should be proportional. Es-
trogens at high doses are used clinically as lactation suppres-
sants, and initiation of lactation is carried out in a relatively
estrogen-free system, although women can and do lactate
after the resumption of their cycles. Contraceptive estrogens
are known to decrease the duration of lactation, and it has
recently been shown that as little as 30 p,g/day of ethinyl
estradiol lowers milk volume in Indian women.'5 Some PCBs
also have estrogenic properties.'6
Although this is a large study in terms of the number of
samples analyzed, larger cohorts would have to be studied to
show small effects of chemical contaminants on specific
illnesses. This study is not suitable for the investigation of
rare, late-onset events, such as cancer. However, we do
continue to keep the cohort under clinical surveillance until
age five and we plan to keep a registry intact after that.
There has been one previous report of shortened dura-
tion of lactation in association with an environmental chem-
ical in breast milk: Weil, et al, observed that women exposed
to polybrominated biphenyls (PBBs) during a food contam-
ination episode in rural Michigan had shorter lactations than
a control group in Ann Arbor.'7 The women had their milk
analyzed and the results available in time to affect their
decision to continue to lactate. There was considerable
concern in Michigan about the toxicity of PBBs, and so it is
plausible that women curtailed lactation on being notified of
their contaminated milk.
The observation of shortened lactation with DDE in the
US leads to speculation on the role of DDT and other
estrogenic pesticides in the lactation failure seen in other
countries. Areas with higher population DDE levels than are
seen in the US offer opportunities to investigate the issue
further.
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